Funds and ETFs China Resources Boya Bio-pharmaceutical Group Co.,Ltd

Equities

300294

CNE100001FF1

Pharmaceuticals

End-of-day quote Shenzhen S.E. 23:00:00 25/04/2024 BST 5-day change 1st Jan Change
31.28 CNY -0.29% Intraday chart for China Resources Boya Bio-pharmaceutical Group Co.,Ltd -1.14% -7.13%

ETFs positioned on China Resources Boya Bio-pharmaceutical Group Co.,Ltd

Name Weight AuM 1st Jan change Investor Rating
0.00% 31 M€ +3.50% -
0.00% 34 M€ +2.14% -
China Resources Boya Bio-pharmaceutical Group Co Ltd, formerly Boya Bio-pharmaceutical Group Co Ltd, is a China-based company principally engaged in the research, development, production and distribution of blood products. The Company's main products include human albumin, freeze-drying intravenous injection human immune globulin, human immune globulin, hepatitis B human immune globulin, hydrophobia human immune globulin, human fibrinogen, metformin hydrochloride, calcium dobesilate capsules, glimepiride and pioglitazone hydrochloride dispersible tablets, among others. The Company's blood products are mainly used in the treatment of tumor, liver diseases and diabetes, among others. The Company also provides diabetic pharmaceuticals and biochemical pharmaceuticals. The Company distributes its products mainly in domestic market.
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
31.28 CNY
Average target price
34.45 CNY
Spread / Average Target
+10.12%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. 300294 Stock
  4. Funds and ETFs China Resources Boya Bio-pharmaceutical Group Co.,Ltd